PATENT CLAIM ANALYSIS

Application Number: 15968376
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "017900"]

Abstract:
The invention relates to a peptide comprising the following amino acid sequence useful as a CCR2 non competitive antagonist peptide.

Claim (Index 1):
A peptide which consists of\n i) X1-TFLK-X3 (SEQ ID NO:18), wherein X1 is glycine or represents an amino acid sequence selected from the group consisting of AG, LG, YLG, and HYLG; and X3 independently is absent, or is alanine; ii) a sequence deriving from SEQ ID NO:18 by one or more chemical modifications that confer resistance to proteolysis; iii) a sequence deriving from SEQ ID NO:18 by one or more conservative substitutions, wherein the peptide possesses CCR2 antagonist activity.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.10526
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14129758', '13003027', '13924501', '13059702', '14244167']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8099879667509334
- 35 USC 102 Novelty (BERT): 0.5808657938936902
- Combined Prediction Score: 0.7870757494652091
- Mean Citation Score: 334.998436
- Max Citation Score: 539.71606
- Similarity Product: 386.38366238226166

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test